The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
Phase I study of teclistamab, a humanized B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in relapsed/refractory multiple myeloma (R/R MM).
 
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Seagen; Skyline Diagnostics; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen Oncology; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; Janssen Oncology; Pharmacyclics; Sanofi; Seagen
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Adaptive Biotechnologies; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pharmamar-zeltia; Takeda
 
Hareth Nahi
No Relationships to Disclose
 
Amrita Y. Krishnan
Stock and Other Ownership Interests - Bristol-Myers Squibb
Consulting or Advisory Role - Adaptive Biotechnologies; Celgene; GlaxoSmithKline; Janssen Oncology; Sutter Medical Group
Speakers' Bureau - Amgen; Celgene; Takeda
Research Funding - Janssen Oncology (Inst)
 
Niels W.C.J. van de Donk
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Janssen; Novartis; SERVIER; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst)
 
Jesus San Miguel
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)
 
Albert Oriol
Consulting or Advisory Role - Amgen; Celgene; Janssen
Speakers' Bureau - Amgen; Celgene
 
Laura Rosiñol
Honoraria - Amgen; Celgene; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag
 
Ajai Chari
Consulting or Advisory Role - Amgen; Antengene; Bristol-Myers Squibb; Celgene; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Novartis; OncoPeptides; Seagen; Secura Bio; Takeda
Research Funding - Amgen; Celgene; Janssen; Novartis; Pharmacyclics; Seagen; Takeda
 
Homer Adams
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Suzette Girgis
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson (I)
 
Shun Xin Wang Lin
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Tara Stephenson
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Kristy Kemmerer
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Jennifer Smit
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Yusri A. Elsayed
No Relationships to Disclose
 
Jeffrey R. Infante
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Jenna D. Goldberg
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Arnob Banerjee
No Relationships to Disclose
 
Alfred L. Garfall
Consulting or Advisory Role - Janssen Oncology; Surface Oncology
Research Funding - Amgen (Inst); Janssen Oncology (Inst); Novartis (Inst); Tmunity Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Patent in the field of CAR T cell therapy